Understanding Bothnian Type Palmoplantar Keratoderma
At a Glance
Bothnian type palmoplantar keratoderma (PPKB) is a rare genetic skin condition causing thickened skin on the palms and soles. Driven by an AQP5 gene mutation, it features extreme skin wrinkling and swelling in water. The condition is lifelong but does not spread to internal organs.
Receiving a diagnosis of Bothnian type palmoplantar keratoderma (PPKB) can feel overwhelming, especially because this condition is quite rare [1]. You may have visited several doctors before finding an answer, as many healthcare providers may not have encountered this specific genetic condition before. It is important to know that while PPKB is a lifelong condition, it is localized to your skin and does not affect your internal organs [1][2].
Understanding Your Diagnosis
Your diagnosis includes several medical terms that describe exactly how the condition behaves. Understanding these terms can help you navigate your care and manage your expectations.
- Diffuse: This means the skin thickening (keratoderma) is uniform across the entire surface of your palms and the soles of your feet, rather than appearing in small spots or patches [1].
- Non-epidermolytic: This refers to the way your skin cells look under a microscope. In “epidermolytic” types, skin cells physically break down or blister easily. In your non-epidermolytic type, the skin cells remain structurally sound, meaning your skin is generally tougher and less prone to spontaneous blistering than other forms of PPK [1].
- Non-progrediens: This is a Latin term meaning “non-progressive.” It means that once the condition fully develops (usually in early childhood), it does not continue to get worse or spread to other parts of the body over time [1]. It stays confined to the palms and soles.
- Autosomal Dominant: This describes how the condition is inherited. It means that only one copy of the altered gene (usually the AQP5 gene) is needed to cause the condition [3][2]. If a parent has the condition, there is a 50% chance of passing it to each child. Speaking with a genetic counselor can be very helpful for family planning and understanding these risks.
The “Hand-in-the-Bucket” Sign
A unique and hallmark feature of PPKB is aquagenic wrinkling [1]. When your skin is exposed to water, it may rapidly swell, turn white, and develop a wrinkled appearance [1]. This is sometimes called the “hand-in-the-bucket” sign.
This happens because of a “gain-of-function” mutation in the AQP5 gene, which controls water channels in your skin [2][4]. Because of this mutation, too many water channels are placed or remain open on the surface of your skin cells, allowing water to enter too easily when they are wet [2]. This leads to rapid swelling, pain, and a sensation of “sponginess” or discomfort after bathing or swimming.
Living with a Rare Condition
Living with a visible, rare skin condition can be challenging. Many patients find that the physical symptoms, such as pain or difficulty with fine motor tasks, can lead to frustration or social anxiety [5][6].
- Quality of Life: Chronic skin thickening can impact your ability to work or enjoy hobbies [5][7]. It is common to feel a psychological burden when managing a condition that others may not understand [7].
- Managing Symptoms: While there is currently no cure, treatments such as retinoids (medications derived from Vitamin A) or specialized keratolytic (skin-softening) creams can help reduce the thickness of the skin and improve mobility [8][9].
- Expert Care: Because PPKB is so rare—historically found most often in people from the Bothnia region of Northern Sweden—it is helpful to work with a dermatologist who specializes in genetic skin disorders [1][10].
While PPKB requires daily management, it is a stable condition. Knowing that it will not progress to other organs or worsen indefinitely can provide a foundation for building an effective long-term care plan [1][2].
Learn More About Managing PPKB
To help you navigate your diagnosis and daily care, we have developed detailed resources:
Symptoms and the 'Water Effect'
Learn about the unique symptoms of Bothnian type palmoplantar keratoderma (PPKB), including the painful water effect, aquagenic wrinkling, and heavy sweating.
Diagnosis and Genetic Testing
Learn about genetic testing for Bothnian type palmoplantar keratoderma (PPKB). Understand the AQP5 gene mutation, inheritance, and how it guides diagnosis.
Daily Management and Skin Care
Learn how to manage Bothnian type palmoplantar keratoderma (PPKB) daily. Understand topical treatments, managing the water effect, and systemic retinoids.
Managing Infections and Odor
Learn how to manage foot odor and infections in Bothnian type palmoplantar keratoderma (PPKB). Understand pitted keratolysis, fungal risks, and treatments.
Common questions in this guide
What does it mean that my PPKB is non-epidermolytic?
Why do my hands swell and wrinkle so much in water?
Will this skin condition eventually spread to other parts of my body?
How is Bothnian type PPK inherited?
Is Bothnian type palmoplantar keratoderma contagious?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What gene was identified in my testing, and how does it confirm my diagnosis of Bothnian type PPK?
- 2.Can you explain my 'non-epidermolytic' status and what that means for how my skin will respond to friction or pressure?
- 3.Given that this is an autosomal dominant condition, what is the likelihood of passing this to my children?
- 4.What topical treatments or lifestyle changes do you recommend specifically for the aquagenic wrinkling (water-induced swelling)?
- 5.Are there any local or national rare disease specialists or genetic counselors you can refer me to?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
The first Danish family reported with an AQP5 mutation presenting diffuse non-epidermolytic palmoplantar keratoderma of Bothnian type, hyperhidrosis and frequent Corynebacterium infections: a case report.
Krøigård AB, Hetland LE, Clemmensen O, et al.
BMC dermatology 2016; (16(1)):7 doi:10.1186/s12895-016-0044-3.
PMID: 27255181 - 2
Bothnian Palmoplantar Keratoderma: Further Delineation of the Associated Phenotype.
Fertitta L, Charbit-Henrion F, Leclerc-Mercier S, et al.
Genes 2022; (13(12)) doi:10.3390/genes13122360.
PMID: 36553627 - 3
AQP5 pathogenic variants induce palmoplantar keratoderma Bothnia type in two Chinese families.
Wang Y, Wang J, Li Y, et al.
The Journal of dermatology 2022; (49(4)):463-468 doi:10.1111/1346-8138.16281.
PMID: 35014096 - 4
Palmoplantar Keratoderma: A Molecular Genetic Analysis of Family Cases.
Shchagina O, Fedotov V, Markova T, et al.
International journal of molecular sciences 2022; (23(17)) doi:10.3390/ijms23179576.
PMID: 36076978 - 5
Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.
Bodemer C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA
The British journal of dermatology 2021; (184(3)):393-400 doi:10.1111/bjd.19144.
PMID: 32307694 - 6
Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.
Zieman AG, Coulombe PA
The British journal of dermatology 2020; (182(3)):564-573 doi:10.1111/bjd.18033.
PMID: 31021398 - 7
Impact of Palmoplantar Dermatoses on Quality of Life.
Singhal R, Diwan NG, Nair PA
Indian dermatology online journal 2018; (9(5)):309-313 doi:10.4103/idoj.IDOJ_347_17.
PMID: 30258797 - 8
Sporadic Diffuse Palmoplantar Keratoderma in a Pediatric Patient With Early Onset: A Case Report.
Premkumar L, Preethi P S, Swaminathan A, Sundaram M
Cureus 2025; (17(12)):e100318 doi:10.7759/cureus.100318.
PMID: 41613660 - 9
Treatment of Painful Palmoplantar Keratoderma Related to Pachyonychia Congenita Using EGFR Inhibitors.
Greco C, Ponsen AC, Leclerc-Mercier S, et al.
Biomedicines 2022; (10(4)) doi:10.3390/biomedicines10040841.
PMID: 35453591 - 10
Transgradient Variant of Mal De Meleda Presenting As Palmoplantar Keratoderma: A Case Report.
Khan A, Singh A, Madke B, et al.
Cureus 2024; (16(5)):e60717 doi:10.7759/cureus.60717.
PMID: 38903266
This page provides educational information about Bothnian type palmoplantar keratoderma. It is not a substitute for professional medical advice, diagnosis, or treatment from a dermatologist or genetic counselor.
Get notified when new evidence is published on Diffuse palmoplantar keratoderma, Bothnian type.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.